Why the study?
Current guidance linking early arrhythmia recurrence to late recurrence is based almost exclusively on thermal ablation, leaving its prognostic relevance after pulsed field ablation uncertain.
Does early arrhythmia recurrence after pulsed field ablation predict late recurrence in patients with atrial fibrillation?
Does early arrhythmia recurrence after pulsed field ablation predict late recurrence in patients with atrial fibrillation?
Early arrhythmia recurrence within 90 days after pulsed field ablation is a strong predictor of late recurrence at 12 months, suggesting the traditional 3-month blanking period remains prognostically relevant for PFA.
Answers are grounded in this paper and cite their sources.
ER after AF ablation signals markedly higher LR risk; leaves open whether early intervention alters long-term outcomes.
Background Current atrial fibrillation (AF) guidelines and expert consensus documents from major societies discuss early arrhythmia recurrence (ER) within the first 3 months after catheter ablation as predictive of late recurrence (LR). These recommendations are based almost exclusively on thermal ablation. With pulsed field ablation (PFA) emerging as a distinct modality with different biophysics and lesion characteristics, the prognostic relevance of ER after PFA remains uncertain. Purpose To explore whether ER after PFA (<3 months) is a predictor for LR at 12 months follow-up. Methods We performed a comprehensive search of PubMed, Embase, and Cochrane databases. ER was defined as AF / atrial flutter / atrial tachycardia >30 s within 90 days; LR as recurrence beyond 3 months. A prognostic meta-analysis was conducted using random-effects models, reporting risk ratios (RR) with 95% confidence intervals (Cl). Prespecified sensitivity analyses included sequential leave-one-out evaluation, and subgroup analyses for paroxysmal, persistent AF and Farapulse-only studies. Results The pooled cohort included 1637 patients (67.7% with paroxysmal AF), with a mean age of 62.5 ± 15.7 years. All studies have a follow-up duration of 12 months. Across all five studies (one randomized trial and four observational), ER showed an association with increased LR (RR 3.61, 95% CI 2.62-4.99; I² = 57%, P = 0.0004). Sequential exclusion of studies reduced heterogeneity to 27% (excluding Mohanty) and 0% (excluding both Mohanty and Di Biase), while maintaining statistical significance, showing great stability (Figure 1). Subgroup analyses showed similar associations in paroxysmal AF (RR 3.27, 95% CI 2.29-4.69) and persistent AF (RR 2.06, 95% CI 1.01-4.18), with no measurable heterogeneity, and within Farapulse-only cohorts (RR 3.83, 95% CI 1.95-7.56, I² = 59%) (Figure 2). Heterogeneity appeared related to differences in monitoring intensity and PFA platforms, while age and AF type showed less variability. Conclusion In this exploratory pooled analysis, ER showed a consistent association with LR. Given that the evidence is predominantly observational and heterogeneous in monitoring intensity, these results should be interpreted cautiously and considered hypothesis-generating. Further prospective randomized trials are needed to clarify whether PFA may require a tailored definition of the blanking period.
No takes yet. Share an insight, caveat, or question.
Bistriceanu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: